Literature DB >> 11095836

The 1998 CDC Sexually Transmitted Diseases Treatment Guidelines.

.   

Abstract

Health care providers who evaluate persons who have or are at risk for sexually transmitted diseases (STDs) should be aware of current national guidelines for STD treatment and should provide assessment and treatment according to these recommendations. The Centers for Disease Control and Prevention STD Treatment Guidelines were developed by using an evidence-based approach incorporating available scientific evidence, specialist knowledge, and consultation with professional organizations and other agencies with diverse perspectives on STD treatment. The guidelines provide recommendations about new antimicrobial agents for the treatment of primary and recurrent genital herpes, a novel patient-applied therapy for genital warts, additional parenteral alternative regimens for the treatment of pelvic inflammatory disease, oral therapy for vaginal candidiasis, and alternative regimens for treatment of chlamydia in pregnancy. Expanded sections in the guidelines also address the management of urethritis, recognition of the acute retroviral syndrome, and the emergence of quinolone-resistant Neisseria gonorrhoeae. Prevention of sexually transmitted hepatitis A and hepatitis B through the use of preexposure vaccinations is discussed.

Entities:  

Year:  2000        PMID: 11095836     DOI: 10.1007/s11908-000-0086-9

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.663


  60 in total

1.  Oral famciclovir for the suppression of recurrent genital herpes: a randomized controlled trial. Collaborative Famciclovir Genital Herpes Research Group.

Authors:  F Diaz-Mitoma; R G Sibbald; S D Shafran; R Boon; R L Saltzman
Journal:  JAMA       Date:  1998-09-09       Impact factor: 56.272

2.  Community-based urine screening for Chlamydia trachomatis with a ligase chain reaction assay.

Authors:  J M Marrazzo; C L White; B Krekeler; C L Celum; W E Lafferty; W E Stamm; H H Handsfield
Journal:  Ann Intern Med       Date:  1997-11-01       Impact factor: 25.391

3.  Patient-initiated, twice-daily oral famciclovir for early recurrent genital herpes. A randomized, double-blind multicenter trial. Canadian Famciclovir Study Group.

Authors:  S L Sacks; F Y Aoki; F Diaz-Mitoma; J Sellors; S D Shafran
Journal:  JAMA       Date:  1996-07-03       Impact factor: 56.272

4.  The clinical diagnosis of genital ulcer disease in men.

Authors:  R P DiCarlo; D H Martin
Journal:  Clin Infect Dis       Date:  1997-08       Impact factor: 9.079

Review 5.  Nongonococcal urethritis--a new paradigm.

Authors:  G R Burstein; J M Zenilman
Journal:  Clin Infect Dis       Date:  1999-01       Impact factor: 9.079

Review 6.  New therapies and prevention strategies for genital herpes.

Authors:  A Wald
Journal:  Clin Infect Dis       Date:  1999-01       Impact factor: 9.079

Review 7.  Treatment of chancroid, 1997.

Authors:  G P Schmid
Journal:  Clin Infect Dis       Date:  1999-01       Impact factor: 9.079

8.  Incidence of pelvic inflammatory disease after first-trimester legal abortion in women with bacterial vaginosis after treatment with metronidazole: a double-blind, randomized study.

Authors:  P G Larsson; J J Platz-Christensen; H Thejls; U Forsum; C Påhlson
Journal:  Am J Obstet Gynecol       Date:  1992-01       Impact factor: 8.661

9.  Doxycycline compared with azithromycin for treating women with genital Chlamydia trachomatis infections: an incremental cost-effectiveness analysis.

Authors:  D Magid; J M Douglas; J S Schwartz
Journal:  Ann Intern Med       Date:  1996-02-15       Impact factor: 25.391

10.  Chlamydia trachomatis infection in a high-risk population: comparison of polymerase chain reaction and cell culture for diagnosis and follow-up.

Authors:  W H Vogels; P C van Voorst Vader; F P Schröder
Journal:  J Clin Microbiol       Date:  1993-05       Impact factor: 5.948

View more
  2 in total

1.  Antimicrobial susceptibility of Neisseria gonorrhoeae isolated in Bangladesh (1997 to 1999): rapid shift to fluoroquinolone resistance.

Authors:  Motiur Rahman; Zafar Sultan; Shirajum Monira; Ashraful Alam; Khairun Nessa; Sonia Islam; Shamsun Nahar; Shahnewaz Alam Khan; Jozef Bogaerts; Nazrul Islam; John Albert
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

2.  Clinical and neuropsychological characteristics of general paresis misdiagnosed as primary psychiatric disease.

Authors:  Wang Yanhua; Shi Haishan; Hou Le; Zhong Xiaomei; Chen Xinru; Li Ling; Wu Zhangying; Zheng Dong; Zhang Yuefen; Tan Yan; Luo Xinni; Liu Sha; Ning Yuping
Journal:  BMC Psychiatry       Date:  2016-07-11       Impact factor: 3.630

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.